The Impact of Thread Length on Implant Stability

NCT ID: NCT05141851

Last Updated: 2021-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

23 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-19

Study Completion Date

2020-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Some studies show that different types of threads in tapered implants result in differences in primary stability. The aim of this study is to a perform a prospective, controlled, randomized clinical trial comparing primary and secondary stability between long and standard thread implants in the treatment of partial edentulous patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study sample consists of 23 maxillary partial edentulous patients, where 32 implants were placed, with threads of 0.7 mm or 0.3 mm in the location of premolars and molars. The comparison, in terms of primary stability, is made by measuring the ISQ value (implant stability quotient), in four locations (buccal, palatal, mesial and distal). Statistical analysis was performed using the independent T-Test.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Implant Stability

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

implant stability; implant threads

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Implants with 0,7mm threads

Placement of Implants with 0,7mm threads

Group Type ACTIVE_COMPARATOR

Implants with 0,7 mm threads

Intervention Type DEVICE

Implants were placed, with threads of 0.7 mm in the location of premolars and molars.

Implants with 0,3mm threads

Placement of Implants with 0,3mm threads

Group Type ACTIVE_COMPARATOR

Implants with 0.3 mm threads

Intervention Type DEVICE

Implants were placed, with threads of 0.3 mm in the location of premolars and molars.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Implants with 0,7 mm threads

Implants were placed, with threads of 0.7 mm in the location of premolars and molars.

Intervention Type DEVICE

Implants with 0.3 mm threads

Implants were placed, with threads of 0.3 mm in the location of premolars and molars.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Minimum 18 years;
* No systemic conditions that contraindicate surgery;
* Periodontal health or periodontal disease treated as part of a periodontal support program and having a high level of plaque control;
* Partial edentulous patients, in the upper jaw, specifically in the location of premolars and molars;

Exclusion Criteria

* Patients with insufficient quantity of bone for implant placement without bone regeneration procedures;
* Patients who underwent medication that could affect stability and osteointegration up to 3 months prior to study initiation;
* Patients with untreated periodontal pathology or who have not followed periodontal supportive treatment;
* Smokers, Pregnant or lactating women.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Lisbon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Vanessa Rocha Rodrigues

Vanessa Rocha Rodrigues

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paulo Mascarenhas, PhD

Role: STUDY_DIRECTOR

University of Lisbon

Susana Noronha, PhD

Role: STUDY_DIRECTOR

University of Lisbon

Vanessa Rodrigues, Dr

Role: PRINCIPAL_INVESTIGATOR

University of Lisbon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vanessa Rodirgues

Lisbon, , Portugal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Portugal

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

The impact of thread length on

Identifier Type: -

Identifier Source: org_study_id